North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Description
In-house Standards
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Sunitinib Malate (CAS: 341031-54-7) is a multi-targeted tyrosine kinase inhibitor used in oncology. It is synthesized via chiral resolution and malic acid salt formation to ensure high purity. The molecular formula is <strong>C22H28N4O5</strong>.</p>
<h3>Application</h3>
<ul>
<li>Treatment of advanced renal cell carcinoma (RCC).</li>
<li>Management of gastrointestinal stromal tumors (GIST).</li>
<li>First-line therapy for metastatic pancreatic neuroendocrine tumors.</li>
</ul>
<h3>Precautions</h3>
<p>Store at controlled room temperature away from moisture. Handle with PPE due to potential toxicity; contraindicated in severe hepatic impairment without dose adjustment.</p>